Form 4 Filing for CalciMedica, Inc. - Stauderman Kenneth A. Stock Option Grant

This filing details a Form 4 submission by Kenneth A. Stauderman, Chief Scientific Officer of CalciMedica, Inc. (CALC). On April 5, 2025, Stauderman was granted an Employee Stock Option to acquire 65,124 shares of Common Stock at a price of $0.00 per share. The option has an exercise price of $0.5850 and expires on April 4, 2036. Vesting is set to begin on April 1, 2026, with 1/48th of the shares vesting monthly over four years, contingent upon the filing of the Company's registration statement on Form S-8 for the shares. As of the report date, Stauderman holds 65,124 shares post-transaction.